irl201104
Peptideexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 29, 2021 (NCT04748536)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05921591 | Phase 1 | May 26, 2023 | Revolo Biotherapeutics |
| NCT05098522 | Phase 2 | Nov 30, 2021 | Revolo Biotherapeutics |
| NCT05084963 | Phase 2 | Nov 30, 2021 | Revolo Biotherapeutics |
| NCT04748536 | Phase 1 | Jan 29, 2021 | Revolo Biotherapeutics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Revolo Biotherapeutics | For profit | 4 | 4 | 2 | 2021 |
1 organizations
Page 1 / 1